Delivery Order SPE2DB20D2104-SPE2DB20FR44M

Award Date 9/11/20

Potential Completion Date 9/14/20

Potential Value $1.2K

Federal Agency

Defense Logistics Agency

Awardee

Amerisourcebergen Drug Corp KABZK8W6PQT3

Ultimate Awardee

Cencora, Inc. NWEGNLYTBDW4

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Chesterbrook, PA, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This federal contract award, valued at $1,234.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for a "Prime Vendor Pharmaceutical Branch - Philadelphia" and has a performance period through September 14, 2020.

The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.

Generated 2/27/25, 11:05 AM